NeoCodex Research Programs
NeoCodex maintains an active program of discovery research, collaborating with a variety of world-class, public, private, academic and corporate institutions.
General Overview
Current proprietary research projects proceed with the shared input of all scientists employed by NeoCodex. Joined with a similar aim to understand the impact of genetic influence on primary disease states of interest, experimental designs approved for pursuit at NeoCodex remain the careful product of combining each Investigator's direction with the overall scientific vision of company's CSO, Agustin Ruiz Laza, MD, PhD. Encouraged to maintain continued communication with colleagues in outside scientific arenas and locations; the diverse scientific team of NeoCodex continues to benefit greatly from fostering an environment in support of open discussion. It is believed that by doing so, NXC Investigators are afforded the opportunity to better understand the issues affecting the changing face of international research, but more importantly, are given encouragement to reflect on the consequences imparted by such issues, simply as members of the international community.
CLINICAL
Main research projects:
Research programs based on AFFY technology:
- Spanish Genome Study (Link)
- Neuroprotection (Alzheimer, Parkinson, Ictus)
- Cancer: Identification of genetic susceptibility factors to suffer cancer: Selection of candidate genes and identification of low penetrance alleles related to the disease.
- RCV Serial Cardiovascular Risk: Identification of genetic factors related to the susceptibility to suffer high blood pressure. Selection of candidate genes and identification of low penetrance alleles related to the disease.
- Infertility: NeoCodex is exploring and uncovering new biomarkers associated to common human reproduction pathologies such azoospermia, oligozoospermia,endometriosis or polycystic ovary syndrome (PCOS)
Alzheimer's disease: Study of candidate genes in patients with late onset Alzheimer's disease: genetic analysis of nuclear factors regulating the expression of CYP2D gene.